Dow Corning Sees Broad Adoption of its LSR Materials for Medical Applications in a Fast-Growing Global Healthcare Industry

Published Nov 12, 2014

Seneffe, Belgium – Rising medical expenditures, increasingly stringent healthcare regulations and growing demand for both disposable and increasingly complex medical devices are all driving healthcare OEMs and fabricators to seek versatile, new material technologies. According to Dow Corning, a global leader in silicones, silicon-based technology and innovation for the medical device industry, these converging trends are accelerating worldwide demand for its broad and growing portfolio of high-performance liquid silicone rubber (LSR) solutions. These include its biomedical-grade Silastic® LSRs, its Dow Corning® Class VI C6 LSRs, its Dow Corning® QP1 LSR product family launched in 2012 and its upcoming Dow Corning® QP1-2XX LSR line planned for launch early next year.